Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Arterial stiffness in subjects with psoriasis: a cross-sectional population study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Blood parameters in a population of blood donors are not affected by hidradenitis suppurativa

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Expert opinion: defining response to omalizumab in patients with chronic spontaneous urticaria

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Diagnostic properties of provocation tests for cold, heat, and delayed-pressure urticaria

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Cause-specific mortality in patients with psoriasis and psoriatic arthritis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Self-reported intake of fruit and vegetables and risk of chronic obstructive pulmonary disease: A nation-wide twin study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Asthma severity and fertility outcome in women with polycystic ovary syndrome: a registry-based study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Comorbidities in vitiligo: comprehensive review

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

Chronic urticaria is an itchy skin disease, which is treated with antihistamines; however, a large group of patients are unresponsive to antihistamines alone and are thus treated with omalizumab, although a small fraction of these patients have particularly recalcitrant disease. Currently, there are no reliable biomarkers available to assess disease activity/severity and treatment response in chronic urticaria patients. However, it has been reported that high levels of D-dimer are observed during disease activity and are significantly reduced during periods of remission. We present a focused overview of studies investigating plasma D-dimer level as a biomarker for disease activity and treatment response in patients with chronic urticaria.

OriginalsprogEngelsk
TidsskriftEuropean Journal of Dermatology
Vol/bind28
Udgave nummer6
Sider (fra-til)731-735
Antal sider5
ISSN1167-1122
DOI
StatusUdgivet - 1 dec. 2018

ID: 56442576